|

Kerendia (Finerenone, BAY94-8862) Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 1

Top Sponsors

  • Peter Rossing1
  • Bayer1

Indications

  • Diabetes2
  • Cardiovascular Autonomic Neuropathy1
  • Diabetic Neuropathies1
  • Type 2 Diabetes Mellitus1
  • Chronic Kidney Disease1

Other2 trials

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea
Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.